Horizon Europe
Partner with the Ferrier Institute for Horizon Europe research.
What sets the Ferrier Institute apart
Our research expertise
Medicinal chemistry and drug discovery
We design and synthesise novel nucleoside-based antivirals, antibacterials, and bile acid derivatives to address infectious diseases and metabolic disorders.
Contact: Team Harris
Glycobiology and carbohydrate chemistry
Our teams isolate, characterise, and modify complex polysaccharides for human health applications, and develop carbohydrate-based biopolymers and therapeutics.
Contact: Team Lamiable-Oulaidi
Rare disease research
We focus on lysosomal storage disorders such as Krabbe and Gaucher diseases, rationally designing small molecules through the enzyme transition state analysis technique.
Contact: Team Lamiable-Oulaidi
Vaccine and immunotherapy development
We create vaccine adjuvants and ionisable lipids for use in next-generation vaccines and immunotherapeutics.
Contact: Team Painter
Natural product chemistry and biosynthesis
We harness natural biosynthetic pathways and computational tools to develop valuable bioactive compounds and study protein communication networks.
Contact: Team Hinkley, Team Parker
Custom synthesis and analytical platforms
Our capabilities include bespoke synthesis, process development, and advanced analytical services, supported by in-house NMR and molecular research platforms.
Contact: Team Rendle
Infrastructure and collaboration
Ferrier operates within a flexible matrix structure, allowing us to resource projects dynamically across our six scientific teams. We offer access to:
- NZ RNA Platform
- NMR facilities
- cGMP Facility (GlycoSyn)
- Websales (GlycoFineChem).
These facilities are available to collaborators and are designed to support complex, multidisciplinary research.